Observational study of telephone consults by stroke experts supporting community tissue plasminogen activator delivery

Academic Emergency Medicine

Volumn 19, Issue 9, 2012, Pages E1027-E1034

  Majersik, Jennifer J ^a   Meurer, William J ^b   Frederiksen, Shirley A ^b   Sandretto, Amaria M ^b   Xu, Zhenzhen ^c   Goldman, Edward B ^b   Scott, Phillip A ^b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

AGED; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG FATALITY; DRUG SAFETY; FEMALE; HUMAN; INTERNET; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MEDICAL EXPERT; MORTALITY; NURSE; OBSERVATIONAL STUDY; PRACTICE GUIDELINE; PRIORITY JOURNAL; STROKE; SYSTEMIC DISEASE; TELECONSULTATION;

EID: 84866417030     PISSN: 10696563     EISSN: 15532712     Source Type: Journal    
DOI: 10.1111/j.1553-2712.2012.01438.x     Document Type: Article

References (27)

1. Kleindorfer D, Lindsell CJ, Brass L, Koroshetz W, Broderick JP,. National US estimates of recombinant tissue plasminogen activator use: ICD-9 codes substantially underestimate. Stroke. 2008; 39: 924-8.
2. Majersik JJ, Smith MA, Zahuranec DB, Sanchez BN, Morgenstern LB,. Population-based analysis of the impact of expanding the time window for acute stroke treatment. Stroke. 2007; 38: 3213-7.
3. Barber PA, Zhang J, Demchuk AM, Hill MD, Buchan AM,. Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility. Neurology. 2001; 56: 1015-20.
4. Brown DL, Barsan WG, Lisabeth LD, Gallery ME, Morgenstern LB,. Survey of emergency physicians about recombinant tissue plasminogen activator for acute ischemic stroke. Ann Emerg Med. 2005; 46: 56-60.
5. Iguchi Y, Kimura K, Shibazaki K, Aoki J,. The number of stroke physicians is the key to preparing IV rt-PA. Cerebrovasc Dis. 2009; 28: 460-7.
6. Faulkner LR, Juul D, Pascuzzi RM, et al., Trends in American Board of Psychiatry and Neurology specialties and neurologic subspecialties. Neurology. 2010; 75: 1110-7.
7. Leira EC, Pary JK, Davis PH, Grimsman KJ, Adams HP Jr,. Slow progressive acceptance of intravenous thrombolysis for patients with stroke by rural primary care physicians. Arch Neurol. 2007; 64: 518-21.
8. Stettler BA, Jauch EC, Kissela B, Lindsell CJ,. Neurologic education in emergency medicine training programs. Acad Emerg Med. 2005; 12: 909-11.
9. Bruce NT, Neil WP, Zivin JA,. Medico-legal aspects of using tissue plasminogen activator in acute ischemic stroke. Curr Treat Options Cardiovasc Med. 2011; 13: 233-9.
10. Meyer BC, Lyden PD, Al-Khoury L, et al., Prospective reliability of the STRokE DOC wireless/site independent telemedicine system. Neurology. 2005; 64: 1058-60.
11. Meyer BC, Raman R, Chacon MR, Jensen M, Werner JD,. Reliability of site-independent telemedicine when assessed by telemedicine-naive stroke practitioners. J Stroke Cerebrovasc Dis. 2008; 17: 181-6.
12. Meyer BC, Raman R, Hemmen T, et al., Efficacy of site-independent telemedicine in the STRokE DOC trial: a randomised, blinded, prospective study. Lancet Neurol. 2008; 7: 787-95.
13. Nelson RE, Saltzman GM, Skalabrin EJ, Demaerschalk BM, Majersik JJ,. The cost-effectiveness of telestroke in the treatment of acute ischemic stroke. Neurology. 2011; 77: 1590-8.
14. Frey JL, Jahnke HK, Goslar PW, Partovi S, Flaster MS,. tPA by telephone: extending the benefits of a comprehensive stroke center. Neurology. 2005; 64: 154-6.
15. Meyer BC, Raman R, Rao R, et al., The STRokE DOC trial technique: 'video clip, drip, and/or ship'. Int J Stroke. 2007; 2: 281-7.
16. Pervez MA, Silva G, Masrur S, et al., Remote supervision of IV-tPA for acute ischemic stroke by telemedicine or telephone before transfer to a regional stroke center is feasible and safe. Stroke. 2010; 41: e18-24.
17. Rymer MM, Thurtchley D, Summers D,. Expanded modes of tissue plasminogen activator delivery in a comprehensive stroke center increases regional acute stroke interventions. Stroke. 2003; 34: e58-60.
18. Switzer JA, Hall C, Gross H, et al., A web-based telestroke system facilitates rapid treatment of acute ischemic stroke patients in rural emergency departments. J Emerg Med. 2009; 36: 12-8.
19. Meurer WJ, Frederiksen SM, Majersik JJ, Zhang L, Sandretto A, Scott PA,. Qualitative data collection and analysis methods: the INSTINCT trial. Acad Emerg Med. 2007; 14: 1064-71.
20. Adams H, Adams R, Del Zoppo G, Goldstein LB,. Guidelines for the early management of patients with ischemic stroke: 2005 guidelines update a scientific statement from the Stroke Council of the American Heart Association/American Stroke Association. Stroke. 2005; 36: 916-23.
21. Scott PA, Frederiksen SM, Kalbfleisch JD, et al., Safety of intravenous thrombolytic use in four emergency departments without acute stroke teams. Acad Emerg Med. 2010; 17: 1062-71.
22. Williams LS, Yilmaz EY, Lopez-Yunez AM,. Retrospective assessment of initial stroke severity with the NIH Stroke Scale. Stroke. 2000; 31: 858-62.
23. Smith EE, Abdullah AR, Petkovska I, Rosenthal E, Koroshetz WJ, Schwamm LH,. Poor outcomes in patients who do not receive intravenous tissue plasminogen activator because of mild or improving ischemic stroke. Stroke. 2005; 36: 2497-9.
24. Smith EE, Fonarow GC, Reeves MJ, et al., Outcomes in mild or rapidly improving stroke not treated with intravenous recombinant tissue-type plasminogen activator: findings from get with the guidelines-stroke. Stroke. 2011; 42: 3110-5.
25. Breuer L, Blinzler C, Huttner HB, Kiphuth IC, Schwab S, Kohrmann M,. Off-label thrombolysis for acute ischemic stroke: rate, clinical outcome and safety are influenced by the definition of 'minor stroke'. Cerebrovasc Dis. 2011; 32: 177-85.
26. Hacke W, Kaste M, Bluhmki E, et al., Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008; 359: 1317-29.
27. Del Zoppo GJ, Saver JL, Jauch EC, Adams HP Jr,. Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association. Stroke. 2009; 40: 2945-8.